Препараты ω3-полиненасыщенных жирных кислот как средство профилактики сердечно-сосудистых осложнений

1. Карпов Ю.А. Профилактика осложнений после перенесенного инфаркта миокарда: роль омега-3 полиненасыщенных жирных кислот. Сердце. 2005; 5: 264-266.

2.

3. Bang Н.О. et al. The composition of the Eskimo food in Northwestern Greenland. Am J Clin Nutr 1980; 33: 2657-66.

4.

5. Kromhout D. et al. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. NEJM 1985; 312: 1205-1209.

6.

7. Siscovick D.S. et al. Dietary intake and cell membrane levels of long chain n3- polyunsaturated fatty acids and the risk of primary cardiac arrest. J Am Med Assoc 1995; 274: 1363-1367.

8.

9. Albert C.M. et al. Blood levels of long chain n-3 fatty acids and the risk of sudden death. N Engl J Med; 2002; 346:1113-1118.

10.

11. Daviglus M.L. et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med; 1997; 336:1046-1053.

12.

13. Hu F.B. et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. J Am Med Assoc. 2002; 287: 1815-1821.

14.

15. Keli S.O. et al. Fish consumption and risk of stroke: the Zutphen Study. Stroke 1994; 25: 328-332.

16.

17. Asherio A. et al. Dietary fat and risk of coronary heart disease in men: cohort study in the United States. BMJ. 1996; 313: 84-90.

18.

19. Williams C.M. et al. Long-chain n-3 PUFA: plant v. marine sources. Proc Nutr Soc. 2006; 65(l):42-50.

20.

21. Natvig H. et al. A controlled trial of the effect of linolenic acid on the incidence of coronary artery disease. Scand J Clin Lab Med 1968; 105 (Suppl): 1-20.

22.

23. Bemelmans W.J. et al. Effect of increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) Study. Am J Clin Nutr. 2002; 75: 221-227.

24.

25. Burr M.L.et al. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 2: 757-761.

26.

27. de Logeril M. et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary artery disease. Circulation 1999; 99: 779-785.

28.

29. Marchioli R. et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the GISSI-Prevenzione. Circulation 2002; 105: 1897-1903.

30.

31. Eritsland J. et al. Effect of dietary supplementation with n-3 fatty acids on coronary artey bypass grafts patency. Am J Cardiol. 1996; 77: 31-36.

32.

33. Gapinski J.P. et al. Preventing restenosis with fish oils following coronary angioplasty: a meta-analysis. Arch Intern Med. 1993; 153: 1595-1601.

34.

35. Billman G.E. et al. Prevention of ischemia-induced sudden cardiac death by puren-3 polyunsaturated fatty acids. Lipids. 1997; 32: 1161-1168.

36.

37. Leaf A. et al. Membrane Effects of the n-3 Fish Oil Fatty Acids, which Prevent Fatal Ventricular Arrhythmias. J Membr Biol. 2005; 206(2):129-139.

38.

39. Xiao Y.F. et al. The Antiarrhythmic Effect of n-3 Polyunsaturated Fatty Acids: Modulation of Cardiac Ion Channels as a Potential Mechanism. J Membr Biol. 2005; 206(2):141-154.

40.

41. Christensen J.H. et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double-blind randomized controlled trial. BMJ. 1996; 312: 677-678.

42.

43. Kleiger R.E. et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987; 59: 256-262.

44.

45. Calo L. et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery. JACC. 2005; 45: 1723-1728.

46.

47. Sellmayer A. et al. Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol. 1995; 76: 974-976.

48.

49. Raitt M. et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. JAMA. 2005; 293: 2884-2891.

50.

51. Harris W.S. N-3 fatty acids and serum lipoproteins: human studies. AmJ Clin Nutr. 1997; 65 (5 Suppl): 1645S-1654S.

52.

53. Harris W.S. Nonpharmacological management of hypertriglyceridemia: focus on fish oils. Clin Cardiol. 1999; 22 (Suppl II): II40-II43.

54.

55. Bhatnagar D. et al. Treatment of mized hyperlipidemia using a combination of omega-3 fatty acids and HMG CoA reductase inhibitor. EHJ. 2001; 3 (Suppl D): D53-D59.

56.

57. Yokoyama M. et al. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). Am Heart J. 2003;146(4):613-620.

58.

59. von Shacky C. et al. The effect of dietary omega-3 fatty acids on coronary aterosclerosis: a randomized, double-blinded, placebo-controlled trial. Ann Intern Med. 1999; 130: 554-562.

60.

61. Kris-Etherton P.M. et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002; 106: 2747-2757.

62.